InStride Health is an innovative, insurance-based specialty provider dedicated to delivering life-changing mental health care for children, teens, and young adults (ages 7-24) struggling with moderate to severe anxiety and Obsessive-Compulsive Disorder (OCD). Founded in 2021 by Harvard-trained clinicians, the company offers a fully virtual, outpatient treatment model grounded in evidence-based practices like Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), with a strong emphasis on real-world exposure therapy. Each patient is supported by a dedicated, multi-disciplinary 3-person care team—consisting of a licensed therapist, a psychiatrist, and an exposure coach. By utilizing custom technology like a video- and chat-enabled mobile app, InStride provides patients with real-time coaching and support exactly when and where they need it most (such as at school or in their community). Backed by major investors like General Catalyst and Mass General Brigham Ventures, InStride Health aims to democratize pediatric behavioral health care by making high-quality, evidence-based treatment more accessible, scalable, and affordable.
